In conclusion, we found that TGF-β promoted renal damage in AKI model, and disruption of Smad2 attenuated cisplatin and I/R-induced kidney injury via reducing programmed cell death of TECs and p65 NF-κB-driven renal inflammation (Figure 10). The gene discussed is TGFB1; the disease is acute kidney injury.